{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:45:58Z","timestamp":1791276358889,"version":"4.1.0"},"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0141946","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T19:10:59Z","timestamp":1446664259000},"page":"e0141946","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":82,"title":["2-Hydroxypropyl-\u03b2-Cyclodextrin Acts as a Novel Anticancer Agent"],"prefix":"10.1371","volume":"10","author":[{"given":"Masako","family":"Yokoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Motoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taishi","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Taniyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Tokumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Tabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Mochinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Sueoka-Aragane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisaburo","family":"Sueoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsumi","family":"Irie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,11,4]]},"reference":[{"key":"ref1","first-page":"5749","article-title":"ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy","volume":"62","author":"AE Wakeling","year":"2002","journal-title":"Cancer Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"BJ Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc3317","article-title":"Pushing the limits of targeted therapy in chronic myeloid leukaemia","volume":"12","author":"T O'Hare","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1172\/JCI43605","article-title":"BCR-ABL kinase is dead; long live the CML stem cell","volume":"121","author":"A Perl","year":"2011","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"JL Goldstein","year":"1990","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature04399","article-title":"Role of cholesterol and lipid organization in disease","volume":"438","author":"FR Maxfield","year":"2005","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1182\/blood-2002-07-2283","article-title":"Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses","volume":"101","author":"HY Li","year":"2003","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cca.2005.10.022","article-title":"Alteration in lipid profile in patients of chronic myeloid leukemia before and after chemotherapy","volume":"366","author":"VS Ghalaut","year":"2006","journal-title":"Clin Chim Acta"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2184.2011.00758.x","article-title":"Cholesterol esters as growth regulators of lymphocytic leukaemia cells","volume":"44","author":"MF Mulas","year":"2011","journal-title":"Cell Prolif"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2353\/ajpath.2006.050959","article-title":"Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents","volume":"168","author":"YC Li","year":"2006","journal-title":"Am J Pathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jcb.10724","article-title":"Cholesterol and prostate cancer","volume":"91","author":"MR Freeman","year":"2004","journal-title":"J Cell Biochem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"33079","DOI":"10.1074\/jbc.M400732200","article-title":"Mevalonate promotes the growth of tumors derived from human cancer cells in vivo and stimulates proliferation in vitro with enhanced cyclin-dependent kinase-2 activity","volume":"279","author":"RE Duncan","year":"2004","journal-title":"J Biol Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0002-9440(10)65706-9","article-title":"Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation","volume":"153","author":"M Rudling","year":"1998","journal-title":"Am J Pathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/blood.V84.8.2689.2689","article-title":"Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in normal and leukemic cells","volume":"84","author":"S Vitols","year":"1994","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.leu.2401856","article-title":"Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin","volume":"14","author":"L Maksumova","year":"2000","journal-title":"Leukemia"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nrd1576","article-title":"Cyclodextrin-based pharmaceutics: past, present and future","volume":"3","author":"ME Davis","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1021\/cr970025p","article-title":"Cyclodextrin Drug Carrier Systems","volume":"98","author":"K Uekama","year":"1998","journal-title":"Chem Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0169-409X(98)00092-1","article-title":"Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development","volume":"36","author":"L Szente","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1248\/bpb.32.700","article-title":"Involvement of lipid rafts of rabbit red blood cells in morphological changes induced by methylated \u03b2-cyclodextrins","volume":"32","author":"K Motoyama","year":"2009","journal-title":"Biol Pharm Bull"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1432-1033.1989.tb15171.x","article-title":"Differential effects of \u03b1-, \u03b2- and \u03b3-cyclodextrins on human erythrocytes","volume":"186","author":"Y Ohtani","year":"1989","journal-title":"Eur J Biochem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.taap.2012.01.007","article-title":"Lipid raft: A floating island of death or survival","volume":"259","author":"KS George","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1172\/JCI0216390","article-title":"Cholesterol, lipid rafts, and disease","volume":"110","author":"K Simons","year":"2002","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0092-8674(01)00472-X","article-title":"Emerging themes in lipid rafts and caveolae","volume":"106","author":"F Galbiati","year":"2001","journal-title":"Cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1126\/science.1068886","article-title":"A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains","volume":"296","author":"RG Anderson","year":"2002","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/path.2531","article-title":"Cholesterol depletion induces anoikis-like apoptosis via FAK down-regulation and caveolae internalization","volume":"218","author":"EK Park","year":"2009","journal-title":"J Pathol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/CAD.0b013e32834a099c","article-title":"Methyl- \u03b2-cyclodextrin induces programmed cell death in chronic myeloid leukemia cells and, combined with imatinib, produces a synergistic downregulation of ERK\/SPK1 signaling","volume":"23","author":"J Yan","year":"2012","journal-title":"Anti-cancer drugs"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijpharm.2013.04.071","article-title":"Involvement of cholesterol depletion from lipid rafts in apoptosis induced by methyl-\u03b2-cyclodextrin","volume":"452","author":"R Onodera","year":"2013","journal-title":"Int J Pharm"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/srep01104","article-title":"Potential use of folate-appended methyl-\u03b2-cyclodextrin as an anticancer agent","volume":"3","author":"R Onodera","year":"2013","journal-title":"Sci Rep"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.2042-7158.2010.01030.x","article-title":"Pharmaceutical applications of cyclodextrins: basic science and product development","volume":"62","author":"T Loftsson","year":"2010","journal-title":"J Pharm Pharmacol"},{"issue":"Suppl 1","key":"ref30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00003495-200161001-00003","article-title":"Pharmacology of itraconazole","volume":"61","author":"K De Beule","year":"2001","journal-title":"Drugs"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymgme.2012.11.005","article-title":"Effects of cyclodextrin in two patients with Niemann-Pick Type C disease","volume":"108","author":"M Matsuo","year":"2013","journal-title":"Mol Genet Metab"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1471-4159.2010.06976.x","article-title":"Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches","volume":"116","author":"AI Rosenbaum","year":"2011","journal-title":"J Neurochem"},{"key":"ref33","first-page":"5995","article-title":"Mutation in the ATP-binding pocket of the ABL kinase domain in an STI571-resistant BCR\/ABL-positive cell line","volume":"62","author":"C Ricci","year":"2002","journal-title":"Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0609.2007.00835.x","article-title":"Establishment and characterization of a novel imatinib-sensitive chronic myeloid leukemia cell line MYL, and an imatinib-resistant subline MYL-R showing overexpression of Lyn","volume":"78","author":"T Ito","year":"2007","journal-title":"Eur J Haematol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/cdd.2010.6","article-title":"Glyoxalase-I is a novel target against Bcr-Abl+ leukemic cells acquiring stem-like characteristics in a hypoxic environment","volume":"17","author":"M Takeuchi","year":"2010","journal-title":"Cell Death Differ"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood-2005-06-2209","article-title":"NS-187, a potent and selective dual Bcr-Abl\/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia","volume":"106","author":"S Kimura","year":"2005","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood-2003-01-0305","article-title":"The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph+ leukemia activity of imatinib mesylate","volume":"102","author":"J Kuroda","year":"2003","journal-title":"Blood"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1248\/bpb.b14-00652","article-title":"Comparative Study of the Anti-leukemic Effects of Imatinib Mesylate, Glivec Tablet and Its Generic Formulation, OHK9511","volume":"38","author":"M Yokoo","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1182\/blood-2010-02-270439","article-title":"NK314 potentiates antitumor activity with adult T-cell leukemia-lymphoma cells by inhibition of dual targets on topoisomerase II\u03b1 and DNA-dependent protein kinase","volume":"117","author":"T Hisatomi","year":"2011","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1182\/blood-2009-07-230292","article-title":"Necdin restricts proliferation of hematopoietic stem cells during hematopoietic regeneration","volume":"114","author":"Y Kubota","year":"2009","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(01)00847-3","article-title":"Oncogenic functions of tumour suppressor p21(Waf1\/Cip1\/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts","volume":"179","author":"IB Roninson","year":"2002","journal-title":"Cancer Lett"},{"key":"ref42","first-page":"2077","article-title":"Differential effects of p21(WAF1\/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties","volume":"62","author":"DJ Bearss","year":"2002","journal-title":"Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"36329","DOI":"10.1074\/jbc.M204962200","article-title":"Transcriptional regulation during p21WAF1\/CIP1-induced apoptosis in human ovarian cancer cells","volume":"277","author":"Q Wu","year":"2002","journal-title":"J Biol Chem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.bjc.6690685","article-title":"Involvement of bcl-2 and p21waf1 proteins in response of human breast cancer cell clones to Tomudex","volume":"81","author":"L Orlandi","year":"1999","journal-title":"Br J Cancer"},{"key":"ref45","first-page":"6234","article-title":"Tumor susceptibility of p21(Waf1\/Cip1)-deficient mice","volume":"61","author":"J Martin-Caballero","year":"2001","journal-title":"Cancer Res"},{"key":"ref46","first-page":"565","article-title":"Targeted inactivation of the p21(WAF1\/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal","volume":"61","author":"WC Yang","year":"2001","journal-title":"Cancer Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0005-2736(74)90331-9","article-title":"Polyene antibiotic-sterol interactions in membranes of Acholesplasma laidlawii cells and lecithin liposomes. II. Temperature dependence of the polyene antibiotic-sterol complex formation","volume":"339","author":"B de Kruijff","year":"1974","journal-title":"Biochim Biophys Acta"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1038\/sj.onc.1201400","article-title":"The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells","volume":"15","author":"D Cortez","year":"1997","journal-title":"Oncogene"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1079-9796(03)00070-6","article-title":"Involvement of Akt kinase in the action of STI571 on chronic myelogenous leukemia cells","volume":"31","author":"K Kawauchi","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.leu.2403241","article-title":"JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis","volume":"18","author":"LS Steelman","year":"2004","journal-title":"Leukemia"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/leu.2011.291","article-title":"Role of stromal microenvironment in nonpharmacological resistance of CML to imatinib through Lyn\/CXCR4 interactions in lipid rafts","volume":"26","author":"Y Tabe","year":"2012","journal-title":"Leukemia"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome","volume":"45","author":"CB Lozzio","year":"1975","journal-title":"Blood"},{"key":"ref53","first-page":"447","article-title":"Establishment of a Ph1-positive human cell line (BV173)","volume":"70","author":"L Pegoraro","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ijc.2910230202","article-title":"K562\u2014a human erythroleukemic cell line","volume":"23","author":"LC Andersson","year":"1979","journal-title":"Int J Cancer"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccr.2009.09.028","article-title":"AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance","volume":"16","author":"T O'Hare","year":"2009","journal-title":"Cancer Cell"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2005.01.007","article-title":"Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl","volume":"7","author":"E Weisberg","year":"2005","journal-title":"Cancer Cell"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.leukres.2006.01.006","article-title":"In vivo antiproliferative effect of NS-187, a dual Bcr-Abl\/Lyn tyrosine kinase inhibitor, on leukemic cells harbouring Abl kinase domain mutations","volume":"30","author":"H Naito","year":"2006","journal-title":"Leuk Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fct.2005.03.007","article-title":"2-Hydroxypropyl-\u03b2-cyclodextrin (HP- \u03b2-CD): a toxicology review","volume":"43","author":"S Gould","year":"2005","journal-title":"Food Chem Toxicol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ymgme.2013.04.010","article-title":"Reply: lung toxicity of hydroxyl-\u03b2-cyclodextrin infusion","volume":"109","author":"M Matsuo","year":"2013","journal-title":"Mol Genet Metab"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymgme.2013.04.003","article-title":"Lung toxicity of hydroxypropyl-\u03b2-cyclodextrin infusion","volume":"109","author":"YH Chien","year":"2013","journal-title":"Mol Genet Metab"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1021\/js960213f","article-title":"Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation","volume":"86","author":"T Irie","year":"1997","journal-title":"J Pharm Sci"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0014-5793(03)00059-0","article-title":"Involvement of cholesterol in the inhibitory effect of dimethyl-\u03b2-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cells","volume":"536","author":"K Yunomae","year":"2003","journal-title":"FEBS Lett"},{"key":"ref63","first-page":"329","article-title":"Choice of cyclodextrin for cellular cholesterol depletion for vascular endothelial cell lipid raft studies: cell membrane alterations, cytoskeletal reorganization and cytotoxicity","volume":"49","author":"AH Hinzey","year":"2012","journal-title":"Indian J Biochem Biophys"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood.V93.4.1308","article-title":"Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach","volume":"93","author":"J Dimitroulakos","year":"1999","journal-title":"Blood"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1182\/blood-2004-01-0395","article-title":"Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells","volume":"104","author":"DE Banker","year":"2004","journal-title":"Blood"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/10428190109097663","article-title":"Lovastatin induced control of blast cell growth in an elderly patient with acute myeloblastic leukemia","volume":"40","author":"MD Minden","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11745-997-0032-1","article-title":"Simvastatin impairs mitogen-induced proliferation of malignant B-lymphocytes from humans\u2014in vitro and in vivo studies","volume":"32","author":"S Vitols","year":"1997","journal-title":"Lipids"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nchembio.1367","article-title":"Niche-based screening identifies small-molecule inhibitors of leukemia stem cells","volume":"9","author":"KA Hartwell","year":"2013","journal-title":"Nat Chem Biol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1073\/pnas.0914309107","article-title":"Endocytosis of \u03b2-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells","volume":"107","author":"AI Rosenbaum","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.chemphyslip.2012.03.007","article-title":"Uptake of a fluorescent methyl-\u03b2-cyclodextrin via clathrin-dependent endocytosis","volume":"165","author":"AP Plazzo","year":"2012","journal-title":"Chem Phys Lipids"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"e41246","DOI":"10.1371\/journal.pone.0041246","article-title":"Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells","volume":"7","author":"C Caliceti","year":"2012","journal-title":"PloS one"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4049\/jimmunol.178.1.455","article-title":"Dysregulation of Src family kinases in mast cells from epilepsy-resistant ASK versus epilepsy-prone EL mice","volume":"178","author":"J Kitaura","year":"2007","journal-title":"J Immunol"},{"key":"ref73","first-page":"2453","article-title":"Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn","volume":"61","author":"PA Tilbrook","year":"2001","journal-title":"Cancer Res"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1042\/BJ20130903","article-title":"Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival","volume":"459","author":"NS Slavova-Azmanova","year":"2014","journal-title":"Biochem J"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1248\/bpb.b14-00726","article-title":"Efficacy of 2-Hydroxypropyl-\u03b2-cyclodextrin in Niemann-Pick Disease Type C Model Mice and Its Pharmacokinetic Analysis in a Patient with the Disease","volume":"38","author":"Y Tanaka","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"ref76","first-page":"33","article-title":"Pharmacokinetics and toxicology of cyclodextrins","author":"KH Fromming","year":"1996"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0141946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T23:07:44Z","timestamp":1599779264000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0141946"}},"subtitle":[],"editor":[{"given":"Connie J","family":"Eaves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,4]]},"references-count":76,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0141946","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,4]]}}}